Form 4 for USPH U S PHYSICAL THERAPY INC /NV
Accepted 2021-12-20 00:00:00 ET · period of report 2021-12-17 · accession 0001209191-21-070494 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-20 | 2021-12-17 | USPH | READING CHRISTOPHER J | CEO, Dir | S - Sale | $93.89 | -12.0K | 69.6K | -15% | -$1.13M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-17 | S | D | 12,000 | $93.89 | 69,638 | D | — | — | (F1) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.75 - $94.00, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. (F2) Includes 24,852 shares which restrictions lapse as to 4,141 on January 1, 2022; 2,876 on each of April 1, July 1 and October 1, 2022; 2,879 shares on January 1, 2023; 1,598 shares on each of April 1, July 1 and October 1, 2023; 1,610 shares on January 1, 2024; and 700 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is employed by the Company on those dates. |